85 related articles for article (PubMed ID: 2516481)
21. Divalent cations in women with PCOS: implications for cardiovascular disease.
Muneyyirci-Delale O; Nacharaju VL; Dalloul M; Jalou S; Rahman M; Altura BM; Altura BT
Gynecol Endocrinol; 2001 Jun; 15(3):198-201. PubMed ID: 11447731
[TBL] [Abstract][Full Text] [Related]
22. [Blood levels of FSH, LH and hPrl in subjects with the polycystic ovary syndrome].
Ragucci N; Izzo A; Amato G
Arch Ostet Ginecol; 1980; 85(4):319-34. PubMed ID: 6807268
[No Abstract] [Full Text] [Related]
23. Prolactin levels in the polycystic ovary syndrome.
Milewicz A
J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
[TBL] [Abstract][Full Text] [Related]
24. VNTR I/I genotype of insulin gene is associated with the increase of follicle number independent from polycystic ovary syndrome.
Haller K; Laisk T; Peters M; Talving E; Karits P; Karro H; Uibo R; Salumets A
Acta Obstet Gynecol Scand; 2007; 86(6):726-32. PubMed ID: 17520407
[TBL] [Abstract][Full Text] [Related]
25. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
[TBL] [Abstract][Full Text] [Related]
26. [Relation between prolactin and dehydroepiandrosterone sulfate in women with polycystic ovary disease].
Bruno B; Poccia G; Masci A
Minerva Endocrinol; 1985; 10(4):223-7. PubMed ID: 2939335
[No Abstract] [Full Text] [Related]
27. Irregular cycles and steroid hormones in polycystic ovary syndrome.
Doi SA; Al-Zaid M; Towers PA; Scott CJ; Al-Shoumer KA
Hum Reprod; 2005 Sep; 20(9):2402-8. PubMed ID: 15932911
[TBL] [Abstract][Full Text] [Related]
28. [Endoscopic treatment of polycystic ovary syndrome. Preliminary data].
Marchino GL; Zaccheo F; Baccarini G; Grio R; Bocci A
Minerva Ginecol; 1989 Nov; 41(11):529-33. PubMed ID: 2533668
[TBL] [Abstract][Full Text] [Related]
29. Hormonal status in prostatic disease.
Frick J; Bartsch G
Prog Clin Biol Res; 1976; 6():143-58. PubMed ID: 66687
[No Abstract] [Full Text] [Related]
30. [Syndrome of familial polycystic ovaries (Stein-Leventhal type): serum levels of luteinizing and follicle stimulating hormones before and after wedge resection of the ovaries].
Toledo SP; Peña EP; Assis LM; Martorelli B; Mattar E
AMB Rev Assoc Med Bras; 1977 May; 23(3):79-82. PubMed ID: 311042
[No Abstract] [Full Text] [Related]
31. Polycystic ovary disease in two patients with Briquet's disorder.
Orenstein H; Raskind MA
Am J Psychiatry; 1983 Sep; 140(9):1202-4. PubMed ID: 6412573
[TBL] [Abstract][Full Text] [Related]
32. [Polycystic ovary syndrome in adolescent gynecology].
Micinski P; Kuczera B; Sirko I; Poreba R
Ginekol Pol; 1999 May; 70(5):370-3. PubMed ID: 10462984
[TBL] [Abstract][Full Text] [Related]
33. Luteinizing Hormone To Follicle Stimulating Hormone Ratio In Patients With Polycystic Ovary Syndrome.
Khattak M; Sultana N; Usman R; Khattak U; Zafar U; Salman H
J Ayub Med Coll Abbottabad; 2020; 32(2):255-258. PubMed ID: 32584004
[TBL] [Abstract][Full Text] [Related]
34. The hormonal profile of women with acne and polycystic ovaries.
Bunker CB; Newton JA; Conway GS; Jacobs HS; Greaves MW; Dowd PM
Clin Exp Dermatol; 1991 Nov; 16(6):420-3. PubMed ID: 1839616
[TBL] [Abstract][Full Text] [Related]
35. [Recent aspects in hormonal diagnosis of polycystic ovaries (PCO)].
Moltz L; Römmler A; Schwartz U; Bidlingmaier F; Hammerstein J
Arch Gynecol; 1979 Jul; 228(1-4):566-7. PubMed ID: 485474
[No Abstract] [Full Text] [Related]
36. [Role of follicle-stimulating and luteinizing hormones in the etiopathogenesis of the Stein-Leventhal syndrome].
Spasov S; Milanov S; Dokumov S; Dashev G
Akush Ginekol (Sofiia); 1975; 14(4):289-92. PubMed ID: 1217664
[No Abstract] [Full Text] [Related]
37. Association of Serum Heavy Metals and Trace Element Concentrations with Reproductive Hormone Levels and Polycystic Ovary Syndrome in a Chinese Population.
Zheng G; Wang L; Guo Z; Sun L; Wang L; Wang C; Zuo Z; Qiu H
Biol Trace Elem Res; 2015 Sep; 167(1):1-10. PubMed ID: 25758722
[TBL] [Abstract][Full Text] [Related]
38. [Polycystic ovary syndrome (PCO syndrome)].
Tojo S; Akahori Y; Katayama K
Nihon Rinsho; 1982; 40(6):1401-6. PubMed ID: 7143743
[No Abstract] [Full Text] [Related]
39. [Drug correction of hormonal disturbances and risk factors of cardiovascular complications in women of reproductive age with polycystic ovary syndrome].
Chernukha GE; Karpov IuA; Balakhonova TV; Blinova IV
Kardiologiia; 2010; 50(12):59-63. PubMed ID: 21591394
[No Abstract] [Full Text] [Related]
40. Study of the effect of metformin on expression levels of TNF-α and IL-18 in animal models of polycystic ovary syndrome.
Ding Z; Chen A; Yao Y; Wang X; Yan L; Cai H; Sun H
Minerva Med; 2021 Oct; 112(5):658-660. PubMed ID: 32207597
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
